Search Tag: ABYSS trial
2024 30 Aug
New research presented at ESC Congress 2024 showed that discontinuing beta-blockers in patients with a history of myocardial infarction (MI) did not demonstrate cardiovascular safety compared to continuation and provided no improvement in patients' quality of life. Advancements in MI management and findings from observational studies have...Read more